Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0348321 (
Haemophilus
)
15,372
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A micromethod utilizing paper discs impregnated with different substrates (Minitek-system) permits differentiation of
Haemophilus
and their biotypes. Differentiation of biotypes presents an assured advantage: it is the only technic for an exact study of non typable H. influenzae strains and
NAD
-dependent
Haemophilus
strains. It is also a complement for study of capsulated H. influenzae. In an epidemiological aspect, this differentiation shows a evident predominance of biotypes I and II for H. influenzae and H. para-influenzae. Except that biotype I includes the larger number of serotypable strains, different serotypes are distributed in the five biotypes of H. influenzae. Likewise none relation has been found between biotypes and antibiotypes.
...
PMID:[Utilization of a micromethod for the differentiation of Haemophilus biotypes. Relations with serotypes and antibiotypes (author's transl)]. 39 66
Haemophilus
parasuis, grown under conditions of high aeration, was found to lack a tricarboxylic acid cycle but to possess phosphoenolpyruvate carboxylase and a reductive pathway leading to the production of succinate. Such organisms contained approximately equal quantities of b-, c-, and d-type cytochromes and excreted acetate. When the oxygen supply for growth was either reduced or eliminated, the specific activities of phosphoenolpyruvate carboxylase, malate dehydrogenase, fumarase, fumarate reductase, and NADH: fumarate oxidoreductase were increased substantially, and the acid products were succinate, acetate, and formate. Organisms grown under the latter conditions also contained increased quantities of b- and c-type cytochromes, some of which were low-potential cytochromes. These low-potential cytochromes were reduced by NADH and oxidized by fumarate, and hence, appeared to be components of NADH: furmarate oxidoreductase. Our results indicate that in H. parasuis, growing aerobically in medium containing glucose, the sole function of the reductive pathway is to provide intermediates for biosynthetic processes, and oxygen is the preferred electron acceptor. As the supply of oxygen is reduced or eliminated, the reductive pathway becomes more involved in
NAD+
recycling and fumarate becomes the acceptor. In effect, irrespective of the oxygen supply, the growth of H. parasuis is absolutely dependent upon the presence of an electron transport system.
...
PMID:Effect of oxygen supply during growth on the production of cytochromes, enzymes, and acid end products by Haemophilus parasuis. 146 68
Strains of Bisgaard taxon 31, isolated from chickens in South Africa suffering from a respiratory disease with clinical symptoms and gross lesions similar to infectious coryza, showed great phenotypical similarities with
Haemophilus
paragallinarum infection except for
NAD
requirement, beta-galactosidase activity and maltose fermentation. Deoxyribonucleic acid-deoxyribonucleic acid hybridization confirmed a high level of genetic relatedness (DNA binding value, 89%) with
Haemophilus
paragallinarum. Guanine + cytosine content and genome size data also support the classification of taxon 31 strains within the species
Haemophilus
paragallinarum.
...
PMID:Occurrence of V-factor (NAD) independent strains of Haemophilus paragallinarum. 149 9
There has not previously been an objective comparison of medium formulations for the primary isolation of
Haemophilus
species. This study was undertaken to evaluate the components required for the optimal growth of large, easily identifiable colonies of these bacteria. We compared six medium bases and seven supplements for their ability to support the growth of 86 strains of
Haemophilus
influenzae and 17 strains of other species of
Haemophilus
. By using a growth index that combines colony size and the dilution factor, a formulation of GC agar base with 1% yeast autolysate and 5% sheep blood (chocolated) promoted the growth of large, easily recognizable colonies of H. influenzae and other
Haemophilus
species. This medium was designated GCYSB. The addition of hematin to supplements that supplied
NAD
(or factor V) to the medium was inhibitory to the growth of all of the
Haemophilus
species tested. In a clinical comparison of GCYSB with routinely used chocolate agar medium in two laboratories for the primary isolation of
Haemophilus
species, overall GCYSB promoted better growth of 124 strains of H. influenzae and H. parainfluenzae. GCYSB is easy to prepare and inexpensive compared with the ease of preparation and expense of other
Haemophilus
isolation media.
...
PMID:Laboratory and clinical evaluations of media for the primary isolation of Haemophilus species. 150 Apr 94
The location of the genes coding for
NAD
independence in four unusual clinical isolates of
Haemophilus
parainfluenzae was determined by transferring these genes to plasmid-free
Haemophilus
influenzae Rd by transformation and analysing transformants for the presence of plasmids by agarose gel electrophoresis. All
NAD
-independent transformants were found to carry a single plasmid species. The plasmids, originally harboured by the four H. parainfluenzae isolates recovered from unrelated sources, were of the same size (5.25 kb). Spontaneous reversion to
NAD
dependence occurred with a low frequency (0.1 to 0.2% of the progeny of a single clone) in both H. parainfluenzae and H. influenzae Rd. The revertants had lost this small plasmid. Mitomycin C exhibited a plasmid 'curing' effect with a frequency of 'curing' of between 1 and 6% of the surviving clones. It was concluded that the genes conferring
NAD
independence were located on the small 5.25 kb plasmid.
...
PMID:Plasmid-mediated NAD independence in Haemophilus parainfluenzae. 177 Mar 56
Exogenous
NAD
, nicotinamide mononucleotide, or nicotinamide riboside is required for the growth of
Haemophilus
influenzae. These compounds have been defined as the V-factor growth requirement. We have previously shown that the internalization of nicotinamide riboside is energy dependent and carrier mediated with saturation kinetics. Thionicotinamide riboside, 3-pyridinealdehyde riboside, 3-acetylpyridine riboside, and 3-aminopyridine riboside were prepared from their corresponding
NAD
analogs. These compounds and several other nicotinamide riboside analogs were evaluated for their ability to support the growth of H. influenzae and for their ability to block the uptake of [carbonyl-14C]nicotinamide riboside by H. influenzae. 3-Aminopyridine riboside blocked the uptake of [carbonyl-14C]nicotinamide riboside and inhibited the growth of H. influenzae when
NAD
, nicotinamide mononucleotide, or nicotinamide riboside served as the V factor. The antibacterial activity of 3-aminopyridine riboside was found to be specific for H. influenzae but had no effect on the growth of Staphylococcus aureus or Escherichia coli. In additional experiments by reversed-phase high-performance liquid chromatography, it was determined that whole cells of H. influenzae degrade 3-aminopyridine adenine dinucleotide to 3-aminopyridine riboside, which is then internalized. Inside the cell, 3-aminopyridine riboside has the ability to interfere with the growth of H. influenzae by an undetermined mechanism.
...
PMID:In vitro evaluation of nicotinamide riboside analogs against Haemophilus influenzae. 214
Previous studies of
Haemophilus
influenzae documented the importance of several pyridine nucleotide-dependent enzymes in processing extracellular
NAD
and NMN to satisfy the V-factor growth requirement of the organism. The substrate specificities of two of these enzymes. NMN:ATP adenylyltransferase and NAD kinase, were investigated following partial purification. The ability of the transferase to utilize 3-acetylpyridine mononucleotide and 3-aminopyridine mononucleotide as substrates for the synthesis of the corresponding dinucleotides was demonstrated. The NAD kinase was observed to accept 3-acetylpyridine adenine dinucleotide as a substrate but failed to utilize 3-aminopyridine adenine dinucleotide. The mononucleotides of 3-acetylpyridine and 3-aminopyridine were shown to be as effective as the corresponding dinucleotides in the support of growth and inhibition of growth of H. influenzae, respectively. Inhibition of growth of H. influenzae by submicromolar 3-aminopyridine adenine dinucleotide was shown to occur because 3-aminopyridine mononucleotide was produced from it in reactions catalysed by the H. influenzae periplasmic nucleotide pyrophosphatase. The presence of an additional important pyridine nucleotide-dependent enzyme, NMN glycohydrolase, is also reported.
...
PMID:Studies of NAD kinase and NMN:ATP adenylyltransferase in Haemophilus influenzae. 216 21
Haemophilus
influenzae D(-)-lactate dehydrogenase (D(-)-lactate:
NAD
oxidoreductase; EC 1.1.1.28) was purified to electrophoretic homogeneity using salt fractionation, hydrophobic and dye affinity chromatography. The enzyme was purified 2100-fold with a 14% recovery and a final specific activity of 300 units/mg protein. The enzyme was demonstrated to be a tetramer of Mr 135,000. The enzyme catalyzed the reduction of pyruvate to give exclusively D(-)-lactate using NADH as coenzyme. The reaction catalyzed was essentially unidirectional, with the oxidation of D-lactate in the presence of
NAD
proceeding at less than 0.2% the rate of pyruvate reduction. Kinetic parameters for the reduction of pyruvate were determined for NADH and four structural analogs of the coenzyme. Coenzyme-competitive inhibition by adenosine derivatives indicated the presence of regions in the coenzyme binding site interacting with the adenosine and pyrophosphate moieties of the coenzyme. The purified enzyme was sensitive to oxidation and was effectively inactivated by sulfhydryl reagents. Conversion of D-lactate to pyruvate catalyzed by a membrane-bound D-lactate oxidase was demonstrated in cell-free extracts of H. influenzae.
...
PMID:Purification and characterization of Haemophilus influenzae D-lactate dehydrogenase. 230 73
Four,
NAD
-independent, clinical isolates of
Haemophilus
parainfluenzae were recovered from a genital ulcer, a purulent skin lesion, a sputum specimen and a throat swab respectively. With the exception of
NAD
requirement, the strains exhibited the biochemical characteristics of H. parainfluenzae biotype II. The genetic relationship between these isolates and a standard strain of H. parainfluenzae was determined by testing transforming activities of two chromosomal markers, streptomycin resistance and nalidixic acid resistance. The clinical isolates were efficient donors and recipients in transformation. In addition, we demonstrated transfer of the genes conferring
NAD
independence to typical,
NAD
-requiring H. parainfluenzae and
Haemophilus
influenzae strains.
...
PMID:Naturally occurring NAD-independent Haemophilus parainfluenzae. 238 41
Previous studies of
Haemophilus
organisms documented the importance of an
NAD+
-dependent malate dehydrogenase in the incomplete tricarboxylic acid cycle present in these organisms. Selective interactions occurring at the coenzyme and substrate binding sites of a purified
Haemophilus
influenzae malate dehydrogenase were investigated. Coenzyme-competitive inhibition by adenosine derivatives demonstrated the presence of regions in the coenzyme binding site that interacted with the adenosine and pyrophosphate moieties of the coenzyme. Positive chainlength effects in the coenzyme-competitive inhibition by aliphatic carboxylic acids indicated the presence of a hydrophobic region at this site that was close to the pyrophosphate region. Seven analogues of
NAD+
that were structurally altered in either the pyridine or purine ring were evaluated as selective inhibitors of the enzyme. The three most effective inhibitors of the purified malate dehydrogenase inhibited the growth of H. influenzae when the organism was grown on a limiting concentration of
NAD+
.
...
PMID:Site-directed inhibition of Haemophilus influenzae malate dehydrogenase. 261 81
1
2
3
4
5
6
7
8
9
10
Next >>